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Background
Systemic juvenile idiopathic arthritis (sJIA) is an autoin-
flammatory disorder, characterized by neutrophilia and
abnormal innate immunity response. Its counterpart in
adult patients is the adult-onset Still’s disease (AOSD).
It has been hypothesized a pathogenic role of neutro-
phils in both conditions, because of patients neutrophi-
lia, maybe related to the typical higher production of
pro-inflammatory cytokines, like IL-1b, whose role in
these disorders should explain the efficacy of IL-1 block-
ers. IL-1b is synthesized as inactive form and its activa-
tion is mediated by the NLRP3 inflammasome.
Increased release of this cytokine in the extracellular
environment lead to a positive feedback loop that perpe-
tuates and amplifies itself stimulation. This mechanism
as well as neutrophils’ activation state could be modified
in sJIA and AOSD.
Objectives
Our aim was to verify possible differences between sJIA
and Still’s patients compared to healthy donors, in term
of PMNs responsiveness to the extracellular environ-
ment and activation state.
Methods
PMNs were obtained from heparinised venous blood of
sJIA patients (n=6), AOSD patients (n=8) and healthy
controls (HC, n=14). All patients’ samples were collected
during stages of active or non-active disease, according to
international disease activity criteria used for the assess-
ment of each disease. After lipopolysaccharide (LPS)
treatment, IL-1b content in PMNs supernatants was
measured by ELISA. CD11b and CD66b expression levels
were measured by flow cytometry, together with intracel-
lular ROS levels through the H2DCFDA ROS-indicator.
Results
In comparison with HC, sJIA and AOSD PMNs showed
an increased IL-1b secretion after LPS or LPS+ATP sti-
mulation (p<0.05). Reduced IL-1b secretion was
observed through caspase-1 inhibitor pre-treatment.
About neutrophils activation state, higher intracellular
ROS levels were detected in PMNs of sJIA patients
(p<0.05) than HC, at basal condition. Moreover, also
CD11b and CD66b surface marker expression levels,
were higher at baseline in sJIA respect HC (p<0.01 and
p<0.05 respectively). Instead, no differences were
obtained between AOSD and HC PMNs.
Conclusions
Data from our proof of concepts study suggest a possible
involvement of PMNs in the pathogenesis of sJIA and
AOSD, since they seem more sensitive to pro-inflamma-
tory stimuli respect healthy controls. An important differ-
ence interests PMNs’ activation state, that seems higher in
sJIA but comparable to HC in AOSD. Further studies are
necessary to confirm and validate these results, but the
trend observed may have a potential role in the direction
of future therapeutic studies.
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